Clinical Trial Update: NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NYX-458 in subjects with mild cognitive impairment or mild dementia due to Parkinson's disease or Lewy body dementia; study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia
• Lewy Body Dementia
• Parkinson Disease

Drugs mentioned

• NYX-458 (nyx-458)

Snippet

Sponsor: Aptinyx | Conditions: Mild Cognitive Impairment, Mild Dementia | Phase 2 | Status: ACTIVE_NOT_RECRUITING